If some bipartisan cooperation continues in Michigan, prescription costs could soon be regulated by the government.

Trump’s planned pharmaceutical tariffs would raise costs by $51bn annually, report finds - Prices of medication and other ...

The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

This is the first part in a series which explores the processes of creating cannabis medicines in Utah, from cultivation and ...

Prescription drug costs continue to climb and are a growing burden on patients, employers and taxpayers.  | Drug cost ...

After unveiling a new drug substance facility in North Carolina in December, Amgen is doubling down on expanding its U.S. | ...

AbbVie Inc. took a little shot at the Trump administration's trade policy, as the drugmaker said Friday that rather than tariffs, tax reform is the key to boosting U.S. manufacturing.

Amgen Inc. will invest $900 million to expand an Ohio manufacturing facility, the latest drug company to promise increased US ...

While AbbVie handily beat expectations this quarter, the company faces declining Humira sales and a challenged aesthetics ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...